XML 15 R5.htm IDEA: XBRL DOCUMENT v3.24.1
Statements of Stockholders' Equity - USD ($)
$ in Thousands
Total
At The Market Sales
Common Stock
Common Stock
At The Market Sales
Additional Paid-In Capital
Additional Paid-In Capital
At The Market Sales
Accumulated Other Comprehensive Loss
Accumulated Deficit
Balance at Dec. 31, 2021 $ 278,526   $ 4   $ 434,196   $ (141) $ (155,533)
Balance, shares at Dec. 31, 2021     41,291,374          
Issuance of common stock and pre-funded warrants, net of issuance costs 76,886   $ 3   76,883      
Issuance of common stock and pre-funded warrants, net of issuance costs, shares     25,429,716          
Issuance of common stock upon exercise of stock options and vesting of restricted stock units 51       51      
Issuance of common stock upon exercise of stock options and vesting of restricted stock units, shares     32,609          
Issuance of common stock pursuant to employee stock purchase plan 329       329      
Issuance of common stock pursuant to employee stock purchase plan, shares     106,192          
Repurchase of common stock related to early exercise of options, shares     (2,778)          
Vesting of early exercised stock options 19       19      
Stock-based compensation 11,467       11,467      
Other comprehensive loss (237)           (237)  
Net loss (123,665)             (123,665)
Balance at Dec. 31, 2022 243,376   $ 7   522,945   (378) (279,198)
Balance, shares at Dec. 31, 2022     66,857,113          
Conversion of convertible preferred stock to common stock upon completion of initial public offering, shares     302,517          
Issuance of common stock in connection with at-the-market sales, net of issuance costs   $ 3,868       $ 3,868    
Issuance of common stock in connection with at-the-market sales, net of issuance costs, shares       535,767        
Issuance of common stock upon exercise of stock options and vesting of restricted stock units 29       29      
Issuance of common stock upon exercise of stock options and vesting of restricted stock units, shares     265,047          
Issuance of common stock pursuant to employee stock purchase plan 653       653      
Issuance of common stock pursuant to employee stock purchase plan, shares     369,898          
Vesting of early exercised stock options 1       1      
Stock-based compensation 15,309       15,309      
Other comprehensive loss 272           272  
Net loss (124,084)             (124,084)
Balance at Dec. 31, 2023 $ 139,424   $ 7   $ 542,805   $ (106) $ (403,282)
Balance, shares at Dec. 31, 2023     68,330,342